Filters

Drugs

Showing results (1901-1910 of 7,083) with videos related to

Pageof 709
Sort By:
Drugs|May 1, 1987
Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertensionS Titmarsh, J P Monk
Drugs|August 31, 2017
Pharmacological Management of Chronic Rhinosinusitis: Current and Evolving TreatmentsDaniel M Beswick, Stacey T Gray, Timothy L Smith
Drugs|July 11, 2016
Lumacaftor/Ivacaftor: A Review in Cystic FibrosisEmma D Deeks
Drugs|July 1, 1986
Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnoticK L Goa, R C Heel
Drugs|July 21, 2017
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in SpasticityAndrea Santamato, Francesco Panza
Drugs|June 15, 2016
Secukinumab: A Review in Psoriatic ArthritisMatt Shirley, Lesley J Scott
Drugs|June 13, 2016
Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future DirectionsAdeeb Bulkhi, Farnaz Tabatabaian, Thomas B Casale
Drugs|January 1, 1987
Microcirculation and neurotransmitter metabolism in the pathophysiology of brain ischaemia. A role for calciumM S Magnoni, S Govoni, M Trabucchi
Drugs|January 1, 1987
Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockersA Uusitalo
Drugs|September 9, 2017
Neratinib: First Global ApprovalEmma D Deeks
Pageof 709

Showing results (1901-1910 of 7,083) with videos related to

Sort By:
Pageof 709
Drugs|May 1, 1987
Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertensionS Titmarsh, J P Monk
Drugs|August 31, 2017
Pharmacological Management of Chronic Rhinosinusitis: Current and Evolving TreatmentsDaniel M Beswick, Stacey T Gray, Timothy L Smith
Drugs|July 11, 2016
Lumacaftor/Ivacaftor: A Review in Cystic FibrosisEmma D Deeks
Drugs|July 1, 1986
Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnoticK L Goa, R C Heel
Drugs|July 21, 2017
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in SpasticityAndrea Santamato, Francesco Panza
Drugs|June 15, 2016
Secukinumab: A Review in Psoriatic ArthritisMatt Shirley, Lesley J Scott
Drugs|June 13, 2016
Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future DirectionsAdeeb Bulkhi, Farnaz Tabatabaian, Thomas B Casale
Drugs|January 1, 1987
Microcirculation and neurotransmitter metabolism in the pathophysiology of brain ischaemia. A role for calciumM S Magnoni, S Govoni, M Trabucchi
Drugs|January 1, 1987
Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockersA Uusitalo
Drugs|September 9, 2017
Neratinib: First Global ApprovalEmma D Deeks
Pageof 709
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us